Ignite Creation Date:
2024-05-06 @ 3:00 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04498078
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-06
First Post:
2020-07-27
Brief Title:
Creatine Supplementation in Autism Spectrum Disorder
Sponsor:
University of Novi Sad Faculty of Sport and Physical Education
Organization:
University of Novi Sad Faculty of Sport and Physical Education
Study Overview
Official Title:
The Effects of Creatine Supplementation in Autism Spectrum Disorder a Randomized Placebo-controlled Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CREATOR
Brief Summary:
Autism Spectrum Disorder ASD is accompanied by reduced levels of total creatine in right temporal-parietal junction and other brain regions of interest and addressing this deficit by exogenous administration of creatine may have beneficial effects on brain metabolism and disease-specific clinical symptoms in patients suffering from ASD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None